2025-08-29 01:31:24
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Sanofi India Ltd reports Q3FY20 PAT of Rs. 132.9 crore
Posted On : 2020-10-27 16:54:48( TIMEZONE : IST )
Sanofi India Ltd has reported financial results for the period ended September 30, 2020.
Financial Results (Q3 CY2020) - QoQ Comparison
The company has reported total income of Rs.701.5 crores during the period ended September 30, 2020 as compared to Rs.739.7 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.132.9 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.136.3 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.57.71 for the period ended September 30, 2020 as compared to Rs.59.18 for the period ended June 30, 2020.
| Financials | Q3 CY2020 | Q2 CY2020 | % Change |
| Total Income | ₹ 701.5 crs | ₹ 739.7 crs |  -5.16% |
| Net Profit | ₹ 132.9 crs | ₹ 136.3 crs | -2.49% |
| EPS | ₹ 57.71 | ₹ 59.18 | -2.48% |
Financial Results (Q3 CY2020) - YoY Comparison
The company has reported total income of Rs.701.5 crores during the period ended September 30, 2020 as compared to Rs.802 crores during the period ended September 30, 2019.
The company has posted net profit / (loss) of Rs.132.9 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.126.6 crores for the period ended September 30, 2019.
The company has reported EPS of Rs.57.71 for the period ended September 30, 2020 as compared to Rs.54.96 for the period ended September 30, 2019.
| Financials | Q3 CY2020 | Q3 CY2019 | % Change |
| Total Income | ₹ 701.5 crs | ₹ 802 crs | -12.53% |
| Net Profit | ₹ 132.9 crs | ₹ 126.6 crs |  4.98% |
| EPS | ₹ 57.71 | ₹ 54.96 | 5% |
Financial Results (9 months ended CY 2020) - YoY Comparison
The company has reported total income of Rs.2255.2 crores during the 9 months period ended September 30, 2020 as compared to Rs.2313.6 crores during the 9 months period ended September 30, 2019.
The company has posted net profit / (loss) of Rs.354.6 crores for the 9 months period ended September 30, 2020 as against net profit / (loss) of Rs.316.9 crores for the 9 months period ended September 30, 2019.
The company has reported EPS of Rs.153.97 for the 9 months period ended September 30, 2020 as compared to Rs.137.59 for the 9 months period ended September 30, 2019.
| Financials | 9 Months Ended CY2020 | 9 Months Ended CY2019 | % Change |
| Total Income | ₹ 2255.2 crs | ₹ 2313.6 crs | -2.52% |
| Net Profit | ₹ 354.6 crs | ₹ 316.9 crs | 11.9% |
| EPS | ₹ 153.97 | ₹137.59 | 11.9% |
Shares of Sanofi India Ltd was last trading in BSE at Rs.8394.65 as compared to the previous close of Rs. 8315.65. The total number of shares traded during the day was 5580 in over 252 trades.
The stock hit an intraday high of Rs. 8442 and intraday low of 8350. The net turnover during the day was Rs. 46871085.
